Author

Paul Desmond 1

1 St Vincent's Hospital, Dept. of Gastroenterology, Fitzroy, Austr

DURABILITY OF RADIOFREQUENCY ABLATION IN BARRETT?S OESOPHAGUS WITH DYSPLASIA: A SEVEN-YEAR AUSTRALIAN EXPERIENCE

Edward HaoJun Tsoi, Georgina Cameron, Puneet Mahindra, Richard Williams, Paul Desmond, Andrew Taylor

FAECAL CALPROTECTIN HELPS DETERMINE THE NEED FOR POST-OPERATIVE COLONOSCOPY IN CROHN’S DISEASE. PROSPECTIVE LONGITUDINAL ENDOSCOPIC VALIDATION. RESULTS FROM THE POCER STUDY.

Emily Wright, Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Steven Leach, Alexandra Gorelik, Lani Prideaux, Danny Liew, Ian Lawrence, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Pe

GOOD AND POOR RESPONDERS TO RADIOFREQUENCY ABLATION FOR BARRETT?S OESOPHAGUS RELATED DYSPLASIA: CAN WE PREDICT WHO THEY ARE?

Edward HaoJun Tsoi, Georgina Cameron, Puneet Mahindra, Richard Williams, Paul Desmond, Andrew Taylor

OPTIMISING POST-OPERATIVE CROHN’S DISEASE MANAGEMENT: BEST DRUG THERAPY ALONE VERSUS ENDOSCOPIC MONITORING WITH TREATMENT STEP-UP. THE POCER STUDY

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

Quantifying Early Gastric Cancer in Australia: What is the potential need for gastric ESD in the West?

Linda Yang, Andrew Taylor, Alexander J Thompson, Paul Desmond, Bronte Holt

RADIOFREQUENCY ABLATION COMBINED WITH ENDOSCOPIC MUCOSAL RESECTION IS SAFE AND EFFECTIVE IN ERADICATING DYSPLASTIC BARRETT’S OESOPHAGUS: UPDATED OUTCOMES FOR THE LARGEST REPORTED AUSTRALIAN EXPERIENCE WITH RFA.

Georgina Cameron, Chatura Jayasekera, Richard Williams, Francesco Amico, Finlay A. Macrae, Paul Desmond, Andrew Taylor

SMOKING IS THE KEY RISK FACTOR THAT DOUBLES THE RISK OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE DESPITE PREVENTIVE DRUG TREATMENT. RESULTS FROM THE POCER STUDY

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

STRATEGIC TIMING OF ANTI-TNF THERAPY IN POSTOPERATIVE CROHN’S DISEASE: COMPARISON OF ROUTINE USE IMMEDIATELY POSTOPERATIVELY WITH SELECTIVE USE AFTER DEMONSTRATED RECURRENCE AT 6 MONTH ENDOSCOPY. RESULTS FROM POCER

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

Item 1 - 8 / 10
1